Myocardial perfusion imaging (MPI) is routinely utilized to noninvasively evaluate patients with suspected or known coronary artery disease (CAD). Although a large armamentarium of imaging techniques is available for this purpose, PET has been shown to possess the highest diagnostic accuracy in detecting CAD [1] . Traditionally, these MPI images are graded in a qualitative manner whereby perfusion defects are identified based on the relative distribution of the tracer. Unfortunately, in conditions with a lack of normal myocardium to act as a reference, such a qualitative approach may yield false-negative results or underestimate the extent of disease (e.g. in multivessel disease and/or microvascular dysfunction). PET, however, additionally offers the possibility to quantify myocardial blood flow (MBF) in absolute terms (i.e. millilitres per minute per gram) when images are acquired in a dynamic fashion [2] . Until recently, quantification of myocardial perfusion was primarily regarded as a research tool because it involved elaborate and time-consuming postprocessing procedures. Advances in PET systems have overcome these limitations and commercially available software packages currently generate quantitative MBF images in the order of minutes with high reproducibility [3] . As a consequence, absolute quantification of flow has ushered into the clinical arena. 
. These observations in various stages of CAD are of interest, but do not provide an answer as to when hyperaemic MBF can be deemed abnormal in an individual patient screened for CAD. The detection of haemodynamically significant CAD is based on the presence of a flow-limiting epicardial coronary lesion, whereas PET MBF measurements reflect the composite of perfusion throughout the entire coronary artery tree (roughly divided into the epicardial coronary compartment and the microvasculature, see Fig. 1 ). Therefore, knowledge of the variability and determinants of the microvascular component of total coronary resistance is of importance to further define the normal limits of quantitative MBF imaging.
In the December 2013 issue of the European Journal of Nuclear Medicine and Molecular Imaging , Liga et al. explore the determinants of hyperaemic MBF using dipyridamole 13 NH 3 PET in symptomatic patients suspected of having CAD, but in whom significant epicardial lesions have been excluded by invasive or CT-based coronary angiography [5] . Such a cohort thus represents a patient population encountered in daily practice and provides clinically relevant information, as opposed to databases of healthy controls. Out of 167 enrolled patients, 100 displayed normal coronary arteries, 41 nonsignificant atherosclerosis, and 26 significant CAD. As anticipated, a gradual decline in hyperaemic MBF was observed across the groups. Multivariate analysis revealed that insulin resistance, the presence of atherosclerosis, and male sex were independently related to impaired hyperaemic perfusion. Upon exclusion of patients with atherosclerosis, gender-related differences in coronary microvascular function remained substantial. Last year, a comparable study by Danad et al. was published in this journal [6] . Although both studies linked a number of traditional cardiovascular risk factors to coronary microvascular dysfunction, the most prominent similarity between them is the impact of gender. These results suggest that in analogy to other clinical parameters (e.g. coronary calcium scoring), interpretation of perfusion values may require correction for gender.
Comparison of these studies also highlights important methodological issues of quantitative perfusion PET. Liga respectively. These major discrepancies in seemingly comparable cohorts of patients were most likely due to the vasodilator and flow tracer utilized. Adenosine appears to induce more potent vasodilation than dipyridamole and these agents should not be considered interchangeable [7] . Perhaps even more profound is the impact of flow tracer utilized. Currently, three PET perfusion tracers are available (H 2 15 O, 13 NH 3 , and 82 Rb). As shown in Fig. 2,  H 2 15 O is the only freely diffusible tracer that can be completely extracted from arterial blood, rendering it ideal for quantifying perfusion, as all observed changes in myocardial tracer activity are solely dependent on perfusion and not affected by flow-dependent rates of extraction [8] . In contrast, 13 NH 3 and particularly 82 Rb display a roll-off phenomenon with a curvilinear extraction rate, resulting in progressive underestimation of MBF at increasing flow quantities.
Correction models for incomplete extraction of tracer can be employed, but induce noise. Even utilizing these models, however, reported perfusion values for specific patient populations gradually decline in parallel with tracer tissue extraction kinetics. In fact, results from studies that have attempted to define optimal cut-off values for hyperaemic MBF to identify significant CAD lack uniformity and clearly display a tracer-specific pattern, with values observed as low as 0.91 mL min [4] . As a consequence, tracer characteristics need to be taken into account when interpreting quantitative MBF obtained with PET.
The study by Liga et al. provides an important insight into the complexities of quantitative MBF imaging and clues as to what issues need to be addressed before its implementation in routine clinical use can be advocated. Future studies should focus on standardizing imaging protocols (regarding radionuclides, scanner hardware, stress agents, compartment models, etc.) and be conducted in a multicentre fashion in carefully selected cohorts of patients with appropriate reference standards to more clearly define the pathophysiological meaning of quantitative MBF on macro-and microvascular health, and help guide therapeutic decision-making to improve outcomes [4, 9] . 
